172 related articles for article (PubMed ID: 12799254)
1. Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.
Mason JO; Fischer DH
Ophthalmology; 2003 Jun; 110(6):1241-4. PubMed ID: 12799254
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750
[TBL] [Abstract][Full Text] [Related]
3. Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.
Pels H; Schmidt-Wolf IG; Glasmacher A; Schulz H; Engert A; Diehl V; Zellner A; Schackert G; Reichmann H; Kroschinsky F; Vogt-Schaden M; Egerer G; Bode U; Schaller C; Deckert M; Fimmers R; Helmstaedter C; Atasoy A; Klockgether T; Schlegel U
J Clin Oncol; 2003 Dec; 21(24):4489-95. PubMed ID: 14597744
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Hoang-Xuan K; Taillandier L; Chinot O; Soubeyran P; Bogdhan U; Hildebrand J; Frenay M; De Beule N; Delattre JY; Baron B;
J Clin Oncol; 2003 Jul; 21(14):2726-31. PubMed ID: 12860951
[TBL] [Abstract][Full Text] [Related]
5. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.
Soussain C; Suzan F; Hoang-Xuan K; Cassoux N; Levy V; Azar N; Belanger C; Achour E; Ribrag V; Gerber S; Delattre JY; Leblond V
J Clin Oncol; 2001 Feb; 19(3):742-9. PubMed ID: 11157026
[TBL] [Abstract][Full Text] [Related]
6. Local methotrexate and dexamethasone phosphate for the treatment of recurrent primary intraocular lymphoma.
Velez G; Boldt HC; Whitcup SM; Nussenblatt RB; Robinson MR
Ophthalmic Surg Lasers; 2002; 33(4):329-33. PubMed ID: 12134997
[TBL] [Abstract][Full Text] [Related]
7. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M;
J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741
[TBL] [Abstract][Full Text] [Related]
8. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
Paulus JA; Bos GM; Löwenberg B; Van Den Bent MJ
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2196-200. PubMed ID: 9864481
[TBL] [Abstract][Full Text] [Related]
9. [Intravitreal chemotherapy for intraocular lymphoma].
Helbig H; Cerny T; de Smet MD
Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
[TBL] [Abstract][Full Text] [Related]
10. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
[TBL] [Abstract][Full Text] [Related]
11. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes.
Hoffman PM; McKelvie P; Hall AJ; Stawell RJ; Santamaria JD
Eye (Lond); 2003 May; 17(4):513-21. PubMed ID: 12802353
[TBL] [Abstract][Full Text] [Related]
12. Management of non Hodgkin's intraocular lymphoma with intravitreal methotrexate.
de Smet MD
Bull Soc Belge Ophtalmol; 2001; (279):91-5. PubMed ID: 11344720
[TBL] [Abstract][Full Text] [Related]
13. Results of combined-modality therapy for primary and secondary malignant lymphoma of the central nervous system (CNS).
Kawamura T; Koga S; Okamoto M; Kanno T; Iwamura H
Radiat Med; 2001; 19(3):145-9. PubMed ID: 11467381
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma.
Sandor V; Stark-Vancs V; Pearson D; Nussenblat R; Whitcup SM; Brouwers P; Patronas N; Heiss J; Jaffe E; deSmet M; Kohler D; Simon R; Wittes R
J Clin Oncol; 1998 Sep; 16(9):3000-6. PubMed ID: 9738568
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of primary cerebral lymphoma].
Delwail V; Bataille B
Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
[TBL] [Abstract][Full Text] [Related]
16. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
17. [Paraplegia following intrathecal chemotherapy].
Beretta F; Sanna P; Ghielmini M; Marini G; Cavalli F
Schweiz Med Wochenschr; 1996 Jun; 126(25):1107-11. PubMed ID: 8711459
[TBL] [Abstract][Full Text] [Related]
18. [Intraocular malignant lymphoma].
Brovkina AF; Sorokina MN; Kaplina AV
Vestn Oftalmol; 1990; 106(6):48-53. PubMed ID: 2075660
[TBL] [Abstract][Full Text] [Related]
19. Intraocular lymphoma: report of three cases and review of the literature.
Trudeau M; Shepherd FA; Blackstein ME; Gospodarowicz M; Fitzpatrick P; Moffatt KP
Am J Clin Oncol; 1988 Apr; 11(2):126-30. PubMed ID: 3282423
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of neuroleukemia by intrathecal administration of cytosar and methotrexate in acute lymphoblastic leukemia in adults].
Filatov LB; Konstantinova TS; Shalaev VA
Ter Arkh; 1999; 71(10):38-40. PubMed ID: 10612172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
